MedPath

AYD001 Phase III Clinical Trial

Phase 3
Conditions
Patients with chronic renal failure undergoing hemodialysis
Registration Number
JPRN-jRCT2031210570
Lead Sponsor
Asaoka Kuniharu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

(1) Patients undergoing hemodialysis for 3 to 5 hours per session, 3 times a week at the time of informed consent.
(2) Patients aged 20 to less than 90 years old.
(3) Patients providing written informed consent about participation in this clinical study

Exclusion Criteria

(1) Patients within 26 weeks of initiating hemodialysis at the time of informed consent
(2) Patients with severe hepatic function impairment
(3) Patients with severe heart disease
(4) Patients with severe respiratory disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath